Phase 4 Eosinophilic oesophagitis Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 4
Step-down Therapy Evaluation of Pantoprazole in Eosinophilic Esophagitis (STEP-EoE): A randomised trial of Pantoprazole at 40mg orally once daily compared to 20mg orally once daily in patients with Eosinophilic esophagitis (EoE) who initially respond to Pantoprazole 40mg orally twice daily.
Eosinophilic oesophagitis (EoE)
Northern Adelaide Local Health Network72 enrolled1 locationACTRN12625001297415
Not Yet Recruiting
Phase 4
Randomised trial of Budesonide Orodispersible tablet (BOT) at 2mg orally once daily compared to 1mg orally once daily in patients with Eosinophilic oesophagitis (EoE) who initially respond to Budesonide 1mg orally twice daily.
Eosinophilic oesophagitis
Northern Adelaide Local Health Network72 enrolled1 locationACTRN12625001296426
Recruiting
Phase 4
Randomized head-to-head trial of proton pump inhibitor (PPI) vs topical corticosteroids (TCs) post food bolus impaction and/or for untreated patients with Eosinophilic esophagitis (EoE).
Eosinophilic oesophagitis (EoE)
Northern Adelaide Local Health Network72 enrolled1 locationACTRN12623000604606